 | Five things you need to know today, and why you should question that map
www.bizjournals.com - March 27 at 3:14 PM |
 | bluebird bio (NASDAQ:BLUE) Price Target Cut to $107.00 by Analysts at BMO Capital Markets
www.americanbankingnews.com - March 27 at 11:52 AM |
| bluebird bio (NASDAQ:BLUE) Receives Hold Rating from William Blair
www.americanbankingnews.com - March 27 at 10:02 AM |
 | Stifel likes bluebird bio in premarket analyst action
seekingalpha.com - March 27 at 8:23 AM |
| $9.24 Million in Sales Expected for bluebird bio Inc (NASDAQ:BLUE) This Quarter
www.americanbankingnews.com - March 27 at 1:42 AM |
| bluebird bio (NASDAQ:BLUE) Stock Rating Upgraded by Stifel Nicolaus
www.americanbankingnews.com - March 26 at 7:46 PM |
| bluebird bio (NASDAQ:BLUE) PT Lowered to at Piper Sandler
www.americanbankingnews.com - March 26 at 7:46 PM |
| bluebird bio (NASDAQ:BLUE) Receives Buy Rating from Wells Fargo & Co
www.americanbankingnews.com - March 26 at 4:11 PM |
 | Biotech delays U.S. gene therapy launch due to outbreak, FDA discord
finance.yahoo.com - March 26 at 2:15 PM |
| bluebird bio Inc (NASDAQ:BLUE) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - March 26 at 1:57 PM |
| Bluebird bio updates on business and clinical programs amid COVID-19
seekingalpha.com - March 26 at 9:14 AM |
 | BRIEF-Bluebird Bio Provides Assessment Of Impact Of COVID-19
www.reuters.com - March 26 at 9:14 AM |
| bluebird bio Provides Assessment of Impact of COVID-19, Update on Business Operations and Clinical Program Development
finance.yahoo.com - March 26 at 9:14 AM |
| -$3.89 Earnings Per Share Expected for bluebird bio Inc (NASDAQ:BLUE) This Quarter
www.americanbankingnews.com - March 26 at 12:48 AM |
 | CAR-T Cell Therapy Market 2020 Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2026
www.benzinga.com - March 24 at 9:13 AM |
 | Global Adrenoleukodystrophy (ALD) Market Report 2020, Featuring Emerging Drugs Lenti D (Bluebird Bio) and Leriglitazone (Minoryx Therapeutics)
www.globenewswire.com - March 20 at 8:25 AM |
 | Gene Therapy Market 2020: Worldwide Industry Overview, Supply Demand and Shortage, Trends, Demand, Overview, Forecast 2026
www.marketwatch.com - March 19 at 9:02 AM |
 | Bluebird Bio Inc
www.bloomberg.com - March 18 at 1:12 PM |
| Adrenoleukodystrophy Drugs Market Future Investment and Forecast 2029 | Applied Genetic Technologies Corp and Bluebird Bio Inc
www.marketwatch.com - March 16 at 7:59 AM |
| Thalassemia Market 2020 Market by Types and Application, Market Segmentation, Industry Share, Trends, Growth Factor Research Report by 2026
www.marketwatch.com - March 13 at 8:38 AM |
| Is T-Cell Immunotherapy Market Trapped Between Growth Expectations and Uncertainty?
www.marketwatch.com - March 12 at 2:01 PM |
 | Is bluebird bio a Millionaire-Making Biotech?
www.fool.com - March 4 at 7:43 AM |
| Zacks: Brokerages Anticipate bluebird bio Inc (NASDAQ:BLUE) Will Announce Quarterly Sales of $9.24 Million
www.americanbankingnews.com - March 4 at 2:28 AM |
| bluebird bio (BLUE) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
seekingalpha.com - February 20 at 1:32 PM |
| bluebird bio, Inc. Just Released Its Annual Results And Analysts Are Updating Their Estimates
finance.yahoo.com - February 20 at 8:31 AM |
 | Stock Alert: Bluebird Bio Stock Down 8% On Mixed Q4 Results
www.nasdaq.com - February 19 at 1:43 PM |
| Why bluebird bio's Q4 Results Really Don't Matter
www.fool.com - February 19 at 8:43 AM |
| bluebird bio Beats Its Q4 Revenue Target but Misses on EPS
www.nasdaq.com - February 18 at 11:13 PM |
| bluebird bio EPS misses by $0.25, beats on revenue
seekingalpha.com - February 18 at 6:13 PM |
| BRIEF-Bluebird Bio Reports Qtrly Net Loss Per Share $4.04
www.reuters.com - February 18 at 6:13 PM |
| bluebird bio Reports Fourth Quarter and Full Year 2019 Financial Results and Highlights Operational Progress
finance.yahoo.com - February 18 at 6:13 PM |
| Some bluebird bio (NASDAQ:BLUE) Shareholders Are Down 35%
finance.yahoo.com - February 17 at 1:40 PM |
| Analysts Estimate Bluebird Bio (BLUE) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - February 13 at 1:53 PM |
| Gene Therapy Market 2020 - 2026, Details in Relation to the Value, Supply Chain Analysis and Recent Technological Developments
www.marketwatch.com - February 12 at 8:33 AM |
| Better Buy: bluebird bio vs. Gilead Sciences
www.nasdaq.com - February 12 at 8:33 AM |
| bluebird bio Announces Upcoming Investor Events
finance.yahoo.com - February 5 at 8:53 AM |
| Gene Therapy Market Growth 2020| Introduction of New Tools in Gene Therapy to Drive the Market
www.marketwatch.com - February 3 at 8:53 AM |
| Bluebird up 2% premarket on two new bullish calls
seekingalpha.com - February 3 at 8:53 AM |
 | bluebird bio, Inc.
247wallst.com - January 30 at 10:35 PM |
| Cancer Gene Therapy Market 2020 Healthcare Analysis and Clinical Reviews Report – Adaptimmune, Bluebird bio, Celgene
www.marketwatch.com - January 28 at 8:00 AM |
| Cancer Gene Therapy Market Size, Share, Analysis, Opportunities and Forecast 2019 - 2025
www.marketwatch.com - January 27 at 7:35 AM |
| Alpha Thalassemia Treatment Market Analysis by Top Companies | Novartis AG, Celgene Corporation, Bluebird Bio, Acceleron Pharma, Shire Plc
www.marketwatch.com - January 27 at 7:35 AM |
| Gene Therapy Market 2020: Development, Key Opportunity, Industry Analysis, Regional Overview, Forecast to 2026
www.marketwatch.com - January 23 at 5:43 PM |
| First Week of March 20th Options Trading For bluebird bio (BLUE)
www.nasdaq.com - January 23 at 5:43 PM |
| Gene Therapy Market Size, Trends, Analysis, Demand, Outlook and Forecast to 2024
www.marketwatch.com - January 20 at 8:42 AM |
| What 's driving Cancer Gene Therapy Market? Stay up-to-date with emerging trends ahead
www.marketwatch.com - January 16 at 6:10 PM |
 | Gene therapies test Europe’s willingness to pay
www.ft.com - January 15 at 11:43 PM |
 | Bluebird Hires New Europe Head as Gene Therapy Rollout Starts
www.msn.com - January 15 at 1:43 PM |
| Bluebird bio launches Zynteglo for TDT in Germany
seekingalpha.com - January 13 at 5:27 PM |
| bluebird bio: CAR-T Pioneer Is A Battleground Stock Among Analysts
seekingalpha.com - January 13 at 4:12 AM |
